was read the article
array:23 [ "pii" => "S2173574310700186" "issn" => "21735743" "doi" => "10.1016/S2173-5743(10)70018-6" "estado" => "S300" "fechaPublicacion" => "2010-03-01" "aid" => "70018" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "copyrightAnyo" => "2010" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2010;6:82-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2612 "formatos" => array:3 [ "EPUB" => 43 "HTML" => 1441 "PDF" => 1128 ] ] "itemSiguiente" => array:18 [ "pii" => "S2173574310700198" "issn" => "21735743" "doi" => "10.1016/S2173-5743(10)70019-8" "estado" => "S300" "fechaPublicacion" => "2010-03-01" "aid" => "70019" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2010;6:86-90" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2240 "formatos" => array:3 [ "EPUB" => 41 "HTML" => 1606 "PDF" => 593 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Haematogenous vertebral osteomyelitis. Experience of a primary care hospital" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "86" "paginaFinal" => "90" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Osteomielitis vertebral hematógena. Experiencia en un hospital comarcal" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Miguel Ruiz Martín, Sergi Ros Expósito, Abelardo Montero Sáez, Pedro Sanz Frutos" "autores" => array:4 [ 0 => array:2 [ "nombre" => "José Miguel" "apellidos" => "Ruiz Martín" ] 1 => array:2 [ "nombre" => "Sergi" "apellidos" => "Ros Expósito" ] 2 => array:2 [ "nombre" => "Abelardo" "apellidos" => "Montero Sáez" ] 3 => array:2 [ "nombre" => "Pedro" "apellidos" => "Sanz Frutos" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700198?idApp=UINPBA00004M" "url" => "/21735743/0000000600000002/v1_201305061606/S2173574310700198/v1_201305061606/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173574310700174" "issn" => "21735743" "doi" => "10.1016/S2173-5743(10)70017-4" "estado" => "S300" "fechaPublicacion" => "2010-03-01" "aid" => "70017" "copyright" => "Sociedad Española de Reumatología and Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Reumatol Clin. 2010;6:76-81" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2320 "formatos" => array:3 [ "EPUB" => 47 "HTML" => 1453 "PDF" => 820 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Churg-Strauss Vasculitis. Description of 9 cases" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "76" "paginaFinal" => "81" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Vasculitis de Jacob Churg y Lotte Strauss. Descripción de 9 casos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Emma García-Melchor, Sonia Mínguez Blasco, Anna Moltó Revilla, Lourdes Mateo Soria, Susana Holgado Pérez, Alejandro Olivé Marqués" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Emma" "apellidos" => "García-Melchor" ] 1 => array:2 [ "nombre" => "Sonia" "apellidos" => "Mínguez Blasco" ] 2 => array:2 [ "nombre" => "Anna" "apellidos" => "Moltó Revilla" ] 3 => array:2 [ "nombre" => "Lourdes" "apellidos" => "Mateo Soria" ] 4 => array:2 [ "nombre" => "Susana" "apellidos" => "Holgado Pérez" ] 5 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Olivé Marqués" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700174?idApp=UINPBA00004M" "url" => "/21735743/0000000600000002/v1_201305061606/S2173574310700174/v1_201305061606/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Treatment with rituximab for thrombocytopenia due to systemic lupus erythematosus" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "82" "paginaFinal" => "85" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Rosa Elena Calderón Saldierna, María Azucena Ramos Sánchez, Yadhira Mejía Holguín, Laura Elena Aranda Baca, María Josefina Sauza del Pozo, Ariana Maia Becerra Márquez" "autores" => array:6 [ 0 => array:4 [ "nombre" => "Rosa Elena" "apellidos" => "Calderón Saldierna" "email" => array:1 [ 0 => "edra.rosa.calderon@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "María Azucena" "apellidos" => "Ramos Sánchez" ] 2 => array:2 [ "nombre" => "Yadhira" "apellidos" => "Mejía Holguín" ] 3 => array:2 [ "nombre" => "Laura Elena" "apellidos" => "Aranda Baca" ] 4 => array:2 [ "nombre" => "María Josefina" "apellidos" => "Sauza del Pozo" ] 5 => array:2 [ "nombre" => "Ariana Maia" "apellidos" => "Becerra Márquez" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Unidad Médica de Alta Especialidad N.° 25 del IMSS, Monterrey, Mexico" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento con rituximab para la trombocitopenia secundaria a lupus eritematoso sistémico" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2009-01-10" "fechaAceptado" => "2009-04-16" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec112367" "palabras" => array:4 [ 0 => "Rituximab" 1 => "Anti CD20" 2 => "Systemic lupus erythematosus" 3 => "Thrombocytopenia" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec112368" "palabras" => array:4 [ 0 => "Rituximab" 1 => "Anti CD20" 2 => "Lupus eritematoso sistémico" 3 => "Trombocitopenia" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Some patients with thrombocytopenia due SLE fail to respond to conventional therapies. Rituximab has been reported to be an alternative for patient treatment.</p> <span class="elsevierStyleSectionTitle">Objective</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To evaluate the response of thrombocytopenia due to Systemic Lupus Erythematosus to the use of Rituximab and patient relapse time at our hospital.</p> <span class="elsevierStyleSectionTitle">Patients and methods</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">We analyzed patients with SLE than received a 2 gram rituximab treatment for thrombocytopenia. We analyzed the rate of patients that achieved complete remission (CR), defined as a platelet count over 100 mil/mm3, partial remission (PR) described as platelets within 50–100 mil/mm3 and no response (NR) if platelets remained unchanged and the time the remission was sustained.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Sixteen treatments were applied to 13 patients, aged 28<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>9 years of age and SLE mean duration time of 68<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>44 months with a mean platelet count of 38<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>29 mil. In 14 treatments (87%) remission was achieved after 5<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2 weeks where 2 patients (12.5%) were non respondent. One of them died due to a massive hemorrhage. The mean response time without relapse was 15.6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6 months. Follow up of three patients was not possible and 3 other died due to infections.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Rituximab is an alternative for treatment of thrombocytopenia due to Systemic Lupus Erythematosus.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">En algunos casos la trombocitopenia secundaria a lupus eritematoso sistémico (LES) no responde al tratamiento convencional. En los últimos años se ha reportado que el rituximab es una alternativa para estos pacientes.</p> <span class="elsevierStyleSectionTitle">Objetivo</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Evaluar la respuesta de la trombocitopenia (T) secundaria a LES con el uso de rituximab y determinar el tiempo que se mantiene el efecto libre de recaída.</p> <span class="elsevierStyleSectionTitle">Material y métodos</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Se revisaron los expedientes de los pacientes con diagnóstico de LES con T que recibieron tratamiento con rituximab (2<span class="elsevierStyleHsp" style=""></span>g) para conocer la proporción de pacientes que lograron remisión completa (RC): definida como una cuenta plaquetaria ><span class="elsevierStyleHsp" style=""></span>100.000/mm3; remisión parcial (RP): cuenta plaquetaria entre 50.000 y 100.000/mm3 y los no respondedores (NR); así como el tiempo que se mantiene el paciente sin recaída.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Se aplicaron 16 tratamientos en 13 pacientes, en una paciente 3 y en otra 2 ciclos. Fueron 12 mujeres y 1 hombre con edad media de 28<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>9 años y tiempo medio de duración del LES de 68<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>44 meses, con una cuenta media plaquetaria de 38.000<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>29.000. En 14 tratamientos (87%) se logró RC después de 5<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2 semanas y 2 pacientes (12.5%) fueron NR. Una de ellas murió por hemorragia masiva. El tiempo medio de respuesta sin recaída fue de 15,6<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>6 meses. Tres pacientes perdieron el seguimiento y 3 murieron de infecciones.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">El rituximab es una alternativa de tratamiento en pacientes con T secundaria a LES.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:24 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic Lupus Erythematosus Mechanisms of disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Rahman" 1 => "D. Isenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra071297" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2008" "volumen" => "358" "paginaInicial" => "929" "paginaFinal" => "939" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18305268" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "European Working Party on Systemic lupus erythematosus.Morbidity and Mortality in Systemic Lupus Erythematosus during a 10-Year period. A comparision of Early and Late Manifestations in a Cohort of 1,000 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Cervera" 1 => "M.A. Khamashta" 2 => "J. Font" 3 => "G.D. Sebastiani" 4 => "A. Gil" 5 => "P. Lavilla" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.md.0000091181.93122.55" "Revista" => array:6 [ "tituloSerie" => "Medicine" "fecha" => "2003" "volumen" => "82" "paginaInicial" => "299" "paginaFinal" => "308" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14530779" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The 1982 revised criteria for the classification of systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.M. Tan" 1 => "A.S. Cohen" 2 => "J.F. Fries" 3 => "A.T. Masi" 4 => "D.J. McShane" 5 => "N.F. Rothfield" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1982" "volumen" => "25" "paginaInicial" => "1271" "paginaFinal" => "1277" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7138600" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "K. Moss" 1 => "Y. Ioannou" 2 => "S.M. Sultan" 3 => "I. Haq" 4 => "D.A. Isenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2002" "volumen" => "61" "paginaInicial" => "409" "paginaFinal" => "413" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11959764" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.M. Ward" 1 => "E. Pyun" 2 => "S. Studenski" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Intern Med" "fecha" => "1996" "volumen" => "156" "paginaInicial" => "1337" "paginaFinal" => "1344" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8651844" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of refractory systemic lupus erythematosusassociated thrombocytopenia with intermittent low-dose intravenous cyclophosphamide" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B. Roach" 1 => "G. Hutchinson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1993" "volumen" => "36" "paginaInicial" => "682" "paginaFinal" => "684" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8489547" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dapsone for autoimmune thrombocytopenic purpura" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Godeau" 1 => "E. Oksenhendler" 2 => "P. Bierling" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Hematology" "fecha" => "1993" "volumen" => "44" "paginaInicial" => "70" "paginaFinal" => "72" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans’ Syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Cervera" 1 => "L.J. Jara" 2 => "S. Pizarro" 3 => "H.L. Enkerlin" 4 => "M. Fernandez" 5 => "F. Medina" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "1995" "volumen" => "22" "paginaInicial" => "1867" "paginaFinal" => "1871" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8991983" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Splenic radiation for corticosteroid-resistant immune thrombocytopenia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Calverley" 1 => "G. Jones" 2 => "J. Kelton" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1992" "volumen" => "116" "numero" => "12 Pt 1" "paginaInicial" => "977" "paginaFinal" => "981" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1586107" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab therapy and Autoimmune Disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Silverman" 1 => "S. Weisman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.10947" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2003" "volumen" => "48" "paginaInicial" => "1484" "paginaFinal" => "1492" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12794814" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Does B cell depletion have a role to play in the treatment of systemic lupus erythematosus?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Gorman" 1 => "M. Leandro" 2 => "D. Isenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2004" "volumen" => "13" "paginaInicial" => "312" "paginaFinal" => "316" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15230284" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab for refractory Evans Syndrome and other immune-mediated hematologic diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "E. Mantadakis" 1 => "V. Danilatou" 2 => "Stiakaki" 3 => "M. Kalmati" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ajh.20180" "Revista" => array:6 [ "tituloSerie" => "Am J Hematol" "fecha" => "2004" "volumen" => "77" "paginaInicial" => "303" "paginaFinal" => "310" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15495242" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Results of treatment with rituximab in three patients with autoimmune hemolytic anemia and or immune thrombocytopenia and a concise review of reported cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "N. Ahrens" 1 => "G. Heymann" 2 => "O. Meyer" 3 => "H. Kiesewetter" 4 => "A. Salama" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Infusionsther Transfusions Med" "fecha" => "2002" "volumen" => "29" "paginaInicial" => "277" "paginaFinal" => "281" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.C. Edwards" 1 => "G. Cambridge" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rheumatology" "fecha" => "2001" "volumen" => "40" "paginaInicial" => "205" "paginaFinal" => "211" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11257159" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of SLE with Anti-CD20 Monoclonal Antibody" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R.J. Looney" 1 => "J. Anolik" 2 => "I. Sanz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000082104" "Revista" => array:6 [ "tituloSerie" => "Curr Dir Autoimmun" "fecha" => "2005" "volumen" => "8" "paginaInicial" => "193" "paginaFinal" => "205" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15564722" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Remission of refractory lupus nephritis whit a protocol including rituximab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.P. Fra" 1 => "G.C. Avanzi" 2 => "E. Bartoli" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2003" "volumen" => "12" "paginaInicial" => "783" "paginaFinal" => "787" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14596429" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow up analysis" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Mexican Hematology Study Group" "etal" => false "autores" => array:5 [ 0 => "J. Garcia-Chavez" 1 => "A. Majluf-Cruz" 2 => "L. Montiel-Cervantes" 3 => "M.G. Esparza" 4 => "J. Vela-Ojeda" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00277-007-0317-3" "Revista" => array:6 [ "tituloSerie" => "Ann Hematol" "fecha" => "2007" "volumen" => "86" "paginaInicial" => "871" "paginaFinal" => "877" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17874322" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Experiencia con rituximab en el tratamiento de pacientes con lupus eritematoso sistémico" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "F.J. Garcia-Hernandez" 1 => "C. Díaz-Cobos" 2 => "J.L. Callejas-Rubio" 3 => "C. Ocaña-Medina" 4 => "N. Ortego- Centeno" 5 => "J. Sánchez-Román" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1699-258X(06)73016-9" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2006" "volumen" => "2" "paginaInicial" => "23" "paginaFinal" => "30" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21794298" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An open study of B lymphocyte depletion in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.J. Leandro" 1 => "J.C. Edwards" 2 => "G. Cambridge" 3 => "M.R. Ehrenstein" 4 => "D.A. Isenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.10541" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2002" "volumen" => "46" "paginaInicial" => "2673" "paginaFinal" => "2677" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12384926" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab chimeric anti-CD 20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Braendstrup" 1 => "O.W. Bjerrum" 2 => "O.J. Nielsen" 3 => "B.A. Jensen" 4 => "N.T. Clausen" 5 => "P.B. Hansen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ajh.20276" "Revista" => array:6 [ "tituloSerie" => "Am J Hematol" "fecha" => "2005" "volumen" => "78" "paginaInicial" => "275" "paginaFinal" => "280" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15795920" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Cooper" 1 => "R. Stasi" 2 => "S. Cunningham-Rundles" 3 => "M. Feuerstein" 4 => "J. Leonard" 5 => "S. Amadori" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2141.2004.04889.x" "Revista" => array:6 [ "tituloSerie" => "Br J Haematol" "fecha" => "2004" "volumen" => "125" "paginaInicial" => "232" "paginaFinal" => "239" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15059147" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "B cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.J. Leandro" 1 => "G. Cambridge" 2 => "J.C. Edwards" 3 => "J. Edwards" 4 => "M.R. Ehrenstein" 5 => "D.A. Isenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/rheumatology/kei080" "Revista" => array:6 [ "tituloSerie" => "Rheumatology" "fecha" => "2005" "volumen" => "44" "paginaInicial" => "1542" "paginaFinal" => "1545" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16188950" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Six refractory lupus patients treated with rituximab: a case series" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.Z. Gillis" 1 => "M. Dall’era" 2 => "A. Gross" 3 => "J. Yazdany" 4 => "J. Davis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.22629" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2007" "volumen" => "57" "paginaInicial" => "538" "paginaFinal" => "542" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17394185" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "B Cell depletion as a novel treatment for systemic lupus erytrematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R.J. Looney" 1 => "J.H. Anolik" 2 => "D. Campbell" 3 => "R.E. Felgar" 4 => "F. Young" 5 => "L.J. Arend" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.20430" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2004" "volumen" => "50" "paginaInicial" => "2580" "paginaFinal" => "2589" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15334472" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000000600000002/v1_201305061606/S2173574310700186/v1_201305061606/en/main.assets" "Apartado" => array:4 [ "identificador" => "17338" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original Article" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000000600000002/v1_201305061606/S2173574310700186/v1_201305061606/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574310700186?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 2 | 4 | 6 |
2024 October | 26 | 38 | 64 |
2024 September | 26 | 16 | 42 |
2024 August | 48 | 32 | 80 |
2024 July | 29 | 38 | 67 |
2024 June | 41 | 29 | 70 |
2024 May | 35 | 46 | 81 |
2024 April | 34 | 29 | 63 |
2024 March | 35 | 38 | 73 |
2024 February | 29 | 27 | 56 |
2024 January | 28 | 24 | 52 |
2023 December | 24 | 26 | 50 |
2023 November | 19 | 27 | 46 |
2023 October | 26 | 30 | 56 |
2023 September | 36 | 42 | 78 |
2023 August | 24 | 12 | 36 |
2023 July | 26 | 21 | 47 |
2023 June | 17 | 21 | 38 |
2023 May | 23 | 18 | 41 |
2023 April | 20 | 17 | 37 |
2023 March | 28 | 29 | 57 |
2023 February | 28 | 34 | 62 |
2023 January | 24 | 22 | 46 |
2022 December | 24 | 30 | 54 |
2022 November | 26 | 30 | 56 |
2022 October | 30 | 29 | 59 |
2022 September | 28 | 43 | 71 |
2022 August | 33 | 40 | 73 |
2022 July | 27 | 42 | 69 |
2022 June | 29 | 30 | 59 |
2022 May | 35 | 50 | 85 |
2022 April | 47 | 42 | 89 |
2022 March | 32 | 41 | 73 |
2022 February | 42 | 26 | 68 |
2022 January | 23 | 44 | 67 |
2021 December | 26 | 54 | 80 |
2021 November | 33 | 53 | 86 |
2021 October | 32 | 72 | 104 |
2021 September | 29 | 59 | 88 |
2021 August | 29 | 52 | 81 |
2021 July | 27 | 39 | 66 |
2021 June | 63 | 49 | 112 |
2021 May | 27 | 46 | 73 |
2021 April | 50 | 55 | 105 |
2021 March | 39 | 28 | 67 |
2021 February | 34 | 20 | 54 |
2021 January | 21 | 19 | 40 |
2020 December | 25 | 20 | 45 |
2020 November | 16 | 18 | 34 |
2020 October | 16 | 14 | 30 |
2020 September | 29 | 20 | 49 |
2020 August | 14 | 14 | 28 |
2020 July | 10 | 16 | 26 |
2020 June | 25 | 18 | 43 |
2020 May | 23 | 14 | 37 |
2020 April | 22 | 18 | 40 |
2020 March | 14 | 10 | 24 |
2020 January | 4 | 0 | 4 |
2019 September | 4 | 0 | 4 |
2019 June | 2 | 0 | 2 |
2019 March | 2 | 0 | 2 |
2019 January | 1 | 0 | 1 |
2018 May | 4 | 1 | 5 |
2018 April | 16 | 9 | 25 |
2018 March | 19 | 13 | 32 |
2018 February | 11 | 8 | 19 |
2018 January | 17 | 4 | 21 |
2017 December | 9 | 6 | 15 |
2017 November | 12 | 9 | 21 |
2017 October | 7 | 17 | 24 |
2017 September | 8 | 10 | 18 |
2017 August | 12 | 14 | 26 |
2017 July | 15 | 14 | 29 |
2017 June | 26 | 30 | 56 |
2017 May | 23 | 24 | 47 |
2017 April | 12 | 10 | 22 |
2017 March | 9 | 11 | 20 |
2017 February | 11 | 20 | 31 |
2017 January | 9 | 12 | 21 |
2016 December | 37 | 21 | 58 |
2016 November | 16 | 12 | 28 |
2016 October | 28 | 11 | 39 |
2016 September | 33 | 9 | 42 |
2016 August | 32 | 8 | 40 |
2016 July | 14 | 2 | 16 |
2016 February | 4 | 11 | 15 |
2016 January | 2 | 17 | 19 |
2015 December | 5 | 0 | 5 |
2015 October | 7 | 11 | 18 |
2015 September | 9 | 0 | 9 |
2015 August | 2 | 0 | 2 |
2015 July | 37 | 4 | 41 |
2015 June | 28 | 25 | 53 |
2015 May | 48 | 34 | 82 |
2015 April | 31 | 36 | 67 |
2015 March | 21 | 25 | 46 |
2015 February | 33 | 36 | 69 |
2015 January | 16 | 34 | 50 |
2014 December | 25 | 25 | 50 |
2014 November | 15 | 42 | 57 |
2014 October | 16 | 34 | 50 |
2014 September | 13 | 32 | 45 |
2014 August | 15 | 48 | 63 |
2014 July | 19 | 29 | 48 |
2014 June | 38 | 27 | 65 |
2014 May | 28 | 27 | 55 |
2014 April | 49 | 24 | 73 |
2014 March | 43 | 29 | 72 |
2014 February | 23 | 19 | 42 |
2014 January | 31 | 22 | 53 |
2013 December | 29 | 17 | 46 |
2013 November | 23 | 20 | 43 |
2013 October | 40 | 15 | 55 |
2013 September | 36 | 19 | 55 |
2013 August | 29 | 16 | 45 |
2013 July | 25 | 20 | 45 |
2013 June | 27 | 22 | 49 |
2013 May | 23 | 23 | 46 |
2013 April | 24 | 19 | 43 |
2013 March | 28 | 24 | 52 |
2013 February | 27 | 10 | 37 |
2013 January | 20 | 14 | 34 |
2012 December | 18 | 11 | 29 |
2012 November | 11 | 19 | 30 |
2012 October | 8 | 8 | 16 |
2012 September | 6 | 5 | 11 |
2012 June | 5 | 0 | 5 |
2012 May | 1 | 0 | 1 |
2012 April | 5 | 0 | 5 |
2012 March | 1 | 0 | 1 |
2012 February | 2 | 0 | 2 |
2012 January | 4 | 0 | 4 |
2011 December | 2 | 0 | 2 |
2011 November | 1 | 0 | 1 |
2011 October | 4 | 0 | 4 |
2011 August | 1 | 0 | 1 |
2011 July | 1 | 0 | 1 |
2011 June | 1 | 0 | 1 |
2011 May | 3 | 0 | 3 |
2011 April | 2 | 0 | 2 |
2011 March | 5 | 0 | 5 |
2011 February | 8 | 0 | 8 |
2011 January | 12 | 0 | 12 |
2010 December | 9 | 0 | 9 |
2010 November | 3 | 0 | 3 |
2010 October | 6 | 0 | 6 |
2010 September | 13 | 0 | 13 |
2010 August | 12 | 0 | 12 |
2010 July | 15 | 0 | 15 |